Wnt signaling pathway inhibitor promotes mesenchymal stem cells differentiation into cardiac progenitor cells in vitro and improves cardiomyopathy in vivo

doi:10.4252/wjsc.v15.i8.821

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 8

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2957)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-9) series, Tables (1-2) series.

Item

Count

PDF

103

WORD

HTML

1780

Figures (1-9)

212

Tables (1-2)

204

Sum=2334

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

145

Download

355

Sum=500

Aug 26, 2023 (publication date) through Nov 3, 2024

Times Cited of This Article

Times Cited (3)

Journal Information of This Article

Publication Name

World Journal of Stem Cells

ISSN

1948-0210

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Stem Cells. Aug 26, 2023; 15(8): 821-841
Published online Aug 26, 2023. doi: 10.4252/wjsc.v15.i8.821

Full Size Figure Download Figure

Figure 8 Hematoxylin-Eosin staining of heart section. Large scan images showing Hematoxylin-Eosin (H&E) stained transverse section of the whole heart. Magnified images showing H&E stained sections in sham control, myocardial infarction (MI) group, mesenchymal stem cells (MSCs) (MI+MSC) group, and inhibitor Wnt production-4 (IWP-4) treated MSCs (MI+IWP-4) group after 4 wk of MI. IWP-4: Inhibitor Wnt production-4; MSC: Mesenchymal stem cell; MI: Myocardial infarction.

Citation: Muneer R, Qazi REM, Fatima A, Ahmad W, Salim A, Dini L, Khan I. Wnt signaling pathway inhibitor promotes mesenchymal stem cells differentiation into cardiac progenitor cells in vitro and improves cardiomyopathy in vivo. World J Stem Cells 2023; 15(8): 821-841
URL: https://www.wjgnet.com/1948-0210/full/v15/i8/821.htm
DOI: https://dx.doi.org/10.4252/wjsc.v15.i8.821